Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Parexel International Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11520
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp – Key Competitors 26
Parexel International Corp – Key Employees 27
Parexel International Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Financial Announcements 33
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36
Corporate Communications 38
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38
Aug 16, 2018: PAREXEL announces appointment of two key executives 40
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43
Government and Public Interest 44
May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44
Other Significant Developments 47
Oct 31, 2018: PAREXEL navigates China’s complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48
Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49
Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29

List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CD Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc, is a diagnostics company that develops immunoassays to improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, incubation of a …
  • Laredo Petroleum, Inc. (LPI)-石油・ガス分野:企業M&A・提携分析
    Summary Laredo Petroleum, Inc. (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enerflex Ltd (EFX):企業の財務・戦略的SWOT分析
    Enerflex Ltd (EFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • First Gen Corp:企業の発電所・SWOT分析2018
    First Gen Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Berlin Packaging, LLC.:企業の戦略・SWOT・財務情報
    Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report Summary Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alliance Healthcare Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • NovaBay Pharmaceuticals Inc (NBY)-製薬・医療分野:企業M&A・提携分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that develops eyecare products. The company’s products include daily lid and lash hygiene spray solution, skin and wound cleanser, and cosetic procedures. Its daily lid and lash hygiene …
  • Frasers Property Limited:企業の戦略・SWOT・財務情報
    Frasers Property Limited - Strategy, SWOT and Corporate Finance Report Summary Frasers Property Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Beckman Research Institute Of The City Of Hope-製薬・医療分野:企業M&A・提携分析
    Summary Beckman Research Institute of The City Of Hope (Beckman Research), a subsidiary of City of Hope is a biomedical research institute that provides a range of healthcare services. The institute provides treatment that includes diabetes progression and treatment, immunology and imaging, mechanis …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Albemarle Corporation:企業の戦略・SWOT・財務情報
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EDP – Energias do Brasil SA:企業の戦略・SWOT・財務情報
    EDP - Energias do Brasil SA - Strategy, SWOT and Corporate Finance Report Summary EDP - Energias do Brasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kasbah Resources Limited:戦略・SWOT・企業財務分析
    Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Jo-Ann Stores, Inc.:戦略・SWOT・企業財務分析
    Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • QuantuMDx Group Ltd:企業の製品パイプライン分析
    Summary QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious dise …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆